This is what analysts have to say about USANA Health Sciences, Inc. (NYSE:USNA) after last week.

December 8, 2017 - By Winifred Garcia

 This is what analysts have to say about USANA Health Sciences, Inc. (NYSE:USNA) after last week.
Investors sentiment increased to 1.47 in 2017 Q2. Its up 0.10, from 1.37 in 2017Q1. It improved, as 21 investors sold USANA Health Sciences, Inc. shares while 32 reduced holdings. 21 funds opened positions while 57 raised stakes. 10.64 million shares or 7.29% more from 9.92 million shares in 2017Q1 were reported.
Natl Bank Of America Corporation De owns 0% invested in USANA Health Sciences, Inc. (NYSE:USNA) for 850 shares. Swiss National Bank holds 0% or 17,800 shares. California Employees Retirement System owns 17,500 shares. Renaissance Technology Ltd Liability Com, New York-based fund reported 1.95M shares. Hays Advisory Limited Liability accumulated 63,790 shares or 1% of the stock. Bogle Inv Mngmt Lp De holds 0.04% or 9,174 shares. The New York-based Blackrock Incorporated has invested 0% in USANA Health Sciences, Inc. (NYSE:USNA). Metropolitan Life Insur invested in 8,070 shares or 0% of the stock. Manufacturers Life Insur Communications The reported 0% of its portfolio in USANA Health Sciences, Inc. (NYSE:USNA). Ny State Common Retirement Fund invested 0% of its portfolio in USANA Health Sciences, Inc. (NYSE:USNA). Smithfield accumulated 160 shares or 0% of the stock. Envestnet Asset reported 673 shares. Texas-based Dimensional Fund Advsrs Limited Partnership has invested 0.02% in USANA Health Sciences, Inc. (NYSE:USNA). First Quadrant Ltd Partnership Ca owns 22,059 shares. Royal Bancorp Of Canada reported 4,978 shares.

USANA Health Sciences, Inc. (NYSE:USNA) Ratings Coverage

Among 3 analysts covering USANA Health Science (NYSE:USNA), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. USANA Health Science had 9 analyst reports since August 6, 2015 according to SRatingsIntel. The rating was maintained by Pivotal Research on Wednesday, February 8 with “Buy”. Sidoti upgraded USANA Health Sciences, Inc. (NYSE:USNA) on Friday, October 16 to “Buy” rating. The company was maintained on Wednesday, October 25 by Pivotal Research. The stock of USANA Health Sciences, Inc. (NYSE:USNA) has “Hold” rating given on Wednesday, August 5 by Pivotal Research. The stock has “Neutral” rating by DA Davidson on Thursday, August 6. The rating was downgraded by Pivotal Research to “Hold” on Monday, May 1. DA Davidson upgraded USANA Health Sciences, Inc. (NYSE:USNA) on Wednesday, September 16 to “Buy” rating. Below is a list of USANA Health Sciences, Inc. (NYSE:USNA) latest ratings and price target changes.

25/10/2017 Broker: Pivotal Research Rating: Buy Old Target: $70.00 New Target: $80.00 Maintain
26/07/2017 Broker: Pivotal Research Rating: Buy New Target: $70.0000

The stock decreased 0.56% or $0.4 during the last trading session, reaching $70.75. About 112,503 shares traded or 3.10% up from the average. USANA Health Sciences, Inc. (NYSE:USNA) has risen 6.87% since December 8, 2016 and is uptrending. It has underperformed by 9.83% the S&P500.

USANA Health Sciences, Inc. develops, makes, and sells science nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company has market cap of $1.70 billion. The firm offers USANA Nutritionals Essentials product line, which includes vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It has a 18.38 P/E ratio. It also provides Sensé—beautiful science products, such as personal care products that support healthy skin and hair through topical nourishment, moisturization, and protection; and other products for prenatal, infant, and young child age groups.

More notable recent USANA Health Sciences, Inc. (NYSE:USNA) news were published by: Marketwatch.com which released: “USANA Health Sciences shares drop after company misses earnings, cuts outlook” on July 25, 2017, also Seekingalpha.com with their article: “USANA Health Sciences’ (USNA) CEO Kevin Guest on Q1 2017 Results – Earnings …” published on May 03, 2017, Seekingalpha.com published: “USANA Health Sciences’ (USNA) CEO David Wentz on Q4 2016 Results – Earnings …” on February 08, 2017. More interesting news about USANA Health Sciences, Inc. (NYSE:USNA) were released by: Seekingalpha.com and their article: “USANA Health Sciences: Strong Moat, Highly Profitable And Growing Sales” published on June 08, 2017 as well as Businesswire.com‘s news article titled: “USANA Health Sciences Announces Appointment of J. Scott Nixon to Board of …” with publication date: October 05, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: